Cargando…
Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
BACKGROUND: To evaluate medicine prices, availability and affordability in Brazil, considering the differences across three types of medicines (originator brands, generics and similar medicines) and different types of facilities (private pharmacies, public sector pharmacies and “popular pharmacies”)...
Autores principales: | Bertoldi, Andréa Dâmaso, Helfer, Ana Paula, Camargo, Aline L, Tavares, Noêmia U L, Kanavos, Panos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511298/ https://www.ncbi.nlm.nih.gov/pubmed/22436555 http://dx.doi.org/10.1186/1744-8603-8-6 |
Ejemplares similares
-
Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021) -
Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform
por: Wouters, Olivier J, et al.
Publicado: (2015) -
Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS)
por: Costa, Karen Sarmento, et al.
Publicado: (2017) -
Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2016) -
The Brazilian private pharmaceutical market after the first ten years of the generics law
por: Bertoldi, Andréa Dâmaso, et al.
Publicado: (2019)